| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.6 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.027 | 0.6 |